Yuyu Pharma begins subject enrolment in Phase II dry eye disease study
The Phase II clinical study will assess the efficacy, safety, and tolerability of YP-P10 to help advance DED patients’ treatment.
South Korea
Latest in
South Korea
SK bioscience Covid-19 vaccine active against BA.1 variant in Phase I/II trial
SKYCovione was jointly developed with the University of Washington School of Medicine’s Institute for Protein Design.
Elevar reports positive Phase II data of adenoid cystic carcinoma therapy
The trial evaluated rivoceranib in 80 patients, including 53 based in the US.
Hyundai Bioscience launches Phase II clinical trial of Covid-19 drug
CP-COV03 is similar to the human efficacy test of penicillin conducted in 1941, in several ways.
SK bioscience-GSK’s Covid-19 vaccine meets Phase III trial’s coprimary goals
The companies have submitted a BLA for SKYCovione to the Korean MFDS on obtaining positive Phase III results.
Shionogi’s Covid-19 antiviral offers quick virus clearance in Asian trials
In the Phase IIb trial of S-217622 that enrolled 428 patients in Japan and South Korea, no serious safety issues…
Genome, Merck partner for Phase II trial combo therapy for biliary tract cancer
The Phase II trial will be sponsored by Genome while MSD will supply Keytruda under the deal.
OliPass begins dosing in Phase IIa trial of painkiller for osteoarthritis
The biotech firm received approval from the Australian regulatory authority for the trial in October last year.